Antitumour activity of ethanolic extract of leaves of Holoptelea integrifolia on Dalton’s ascitic lymphoma in Swiss albino mice
DOI:
https://doi.org/10.22377/ijgp.v4i1.118Abstract
The antitumour activity of the ethanolic extract of leaves of Holoptelea integrifolia (EHI) has been evaluated against Dalton’s ascitic lymphoma (DAL) in Swiss albino mice at the dose of 250 and 500 mg/kg, body weight. The experimental parameters were evaluated like tumour volume, tumour cell count, viable tumour cell count, mean survival time and increase in life span to assess antitumour activity. The extract was administered orally for 14 consecutive days to tumour bearing group of animals. The extract increased the life span of DAL treated mice and restored the hematological parameters as compared with the DAL bearing mice in a dose-dependant manner. The study revealed that the EHI showed significant antitumour activity in tested animal models.Key words: Holoptelea integrifolia, Dalton’s ascitic lymphoma, lifespan, tumour volume
Downloads
References
Ramakrishna Y, Manohor AI, Mamata P, Shreekant KG. Plants and
novel antitumour agents: A review. Indian Drugs 1984;21:173-85.
Anonymous, Wealth of India, Raw Materials. Vol. V, 2001. New
Delhi: Publication and Information Directorate (CSIR); India.
p. 109.
Rajbhandari M, Wegner U, Jülich M, Schöpke T, Mentel R.
Screening of Nepalese medicinal plants for antiviral activity. J
Ethnopharmacol 2001;74:251-5.
Srinivas Reddy B, Kiran Kumar Reddy R, Naidu VG,
Madhusudhana K, Agwane SB, Ramakrishna S, et al. Evaluation
of antimicrobial, antioxidant and wound-healing potentials of
Holoptelea integrifolia. J Ethnopharmacol 2008;115:249-56.
Bambhole VB, Jiddewar GG. Anti-obesity effect of Iris versicolor
and Holoptelea integrifolia in rats. Sachitra Ayurved 1985;37:557-61.
Graham JG, Quinn ML, Fabricant DS, Farnsworth NR. Plants used
against cancer-an extension of the work of Jonathan Hartwell. J
Ethnopharmacol 2000;73:347-77.
Gothoskar SV, Ranadive KJ. Anticancer screening of SAN-AB; an
extract of marking nut, Semicarpus anacardium. Indian J Exp Biol
;9:372-5.
Sharma S, Lakshmi KS, Patidar A, Chaudhary A, Dhaker S.
Studies on anti-inflammatory effect of aqueous extract of leaves
of Holoptelea integrifolia, Planch. in rats. Indian J Pharmacol
;41:87-8.
Mazumdar UK, Gupta M, Maiti S, Mukherjee D. Antitumour
activity of Gygrophila spinosa on Ehrlich ascites carcinoma and
sarcoma-180 induced mice. Indian J Exp Biol 1997;35:473-7.
Sur P, Ganguly DK. Tea plant root extract (TRE) as an antineoplastic
agent. Planta Med 1994;60:106-9.
Dacie JV, Lewis SM. Practical Hematology. 2nd ed. J and A Churchill,
London. 1958. p. 38-48.
D’Armour FE, Blood FR, Belden DA. The Manual for Laboratory
Work in Mammalian Physiology. 3rd ed. The University of Chicago
Press, Illinois. 1965. p. 4-6.
Clarkson BD, Burchenal JH. Preliminary screening of antineoplastic
drugs. Progress Clin Cancer 1965;1:625-9.
Obiling C, Guerin M. The Role of Viruses in the Production of
Cancer. Adv Cancer Res II . Academic Press: New York; 1954. p.
-11.
Price VE, Greenfield RE. Anemia in cancer. In: Grenstein, J.P.,
Haddow, A. (Eds.), Advance in Cancer Research, vol. 5. Academic
Press: New York; p. 199-200.
Hogland HC. Hematological complications of cancer chemotherapy.
Sem Oncol 1982;9:95-102.
Brown JP. A review of the genetic effect of naturally occurring
flavonoids, anthraquinones and related compounds. Mutat Res
;75;243-7.
Hirano T, Oka K, Akiba M. Antiproliferative effect of synthetic and
naturally occurring flavonoids on tumour cells of human breast
carcinoma cell lines, ZR-75-1. Res Commun Pathol Pharmacol
;64:69-78.
Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M,
et al. Increased signal transduction activity and down regulation
in human cancer cells. Anticancer Res. 1996;16:3271-82.
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H,
et al. Flavonoids, dietary-derived inhibitors of cell proliferation
and in vitro angiogenesis. Cancer Res 1997;57:2916-21.
